117 - 52-WEEKS RISANKIZUMAB SUBCUTANEOUS MAINTENANCE DOSING IS EFFICACIOUS AND WELL TOLERATED IN PATIENTS WITH MODERATE TO SEVERE CROHN’S DISEASE WHO HAD DELAYED RESPONSE TO 12-WEEKS IV RISANKIZUMAB INDUCTION
| Autor: | Geert D’Haens, Remo Panaccione, Julián Panés, Tadakazu Hisamatsu, Peter Bossuyt, Silvio Danese, Ezequiel Neimark, Alexandra Song, Xiaomei Liao, Kori Wallace, Javier Zambrano, W Rachel Duan, Kristina Kligys, Marla Dubinsky |
|---|---|
| Rok vydání: | 2023 |
| Předmět: | |
| Zdroj: | Gastroenterología y Hepatología. 46:S149 |
| ISSN: | 0210-5705 |
| DOI: | 10.1016/s0210-5705(23)00249-2 |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|